A patient with systemic lupus erythematosus (SLE) may develop a protein-losing enteropathy.
Occasionally the onset of the enteropathy may be the first sign of SLE.
Most affected patients are young females.
Clinical features:
(1) low serum albumin
(2) peripheral edema, includng anasarca
(3) elevation of the alpha-1-antitrypsin clearance in the stool
(4) improvement following the initiation of therapy directed against SLE-related protein-losing enteropathy
Exclusions:
(1) absence of nephropathy
(2) absence of protein malnutrition
(3) no or mild constrictive pericarditis (not severe enough to explain the protein loss)
(4) absence of chronic liver disease
(5) absence of steatorrhea
(6) absence of intestinal lymphangiectasia
Variable findings:
(1) diarrhea
(2) nausea and/or vomiting
(3) malaise and/or fatigue
(4) low serum complement
(5) elevated serum cholesterol
Purpose: To evaluate a patient for SLE-associated protein losing enteropathy.
Specialty: Immunology/Rheumatology
Objective: risk factors, clinical diagnosis, including family history for genetics, imaging studies, laboratory tests, complication detection, prevention
ICD-10: M32.0, M32.1, M32.8, M32.9,